Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors
============================================================================================================================================================================

* Ben Tran
* Richard D. Carvajal
* Aurelien Marabelle
* Sandip Pravin Patel
* Patricia M. LoRusso
* Erik Rasmussen
* Gloria Juan
* Vijay V. Upreti
* Courtney Beers
* Gataree Ngarmchamnanrith
* Patrick Schöffski